Angiodynamics (ANGO) Cash from Operations (2010 - 2026)

Angiodynamics has reported Cash from Operations for 17 years, with the latest figure at 3110000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 76.37% year-over-year to 3110000.0; the trailing twelve-month figure through Feb 2026 stood at 4448000.0 (up 118.58% YoY), and the FY2025 full-year result was 10128000.0, up 64.03% from the prior year.
• Cash from Operations for Q1 2026 stood at 3110000.0, down from 4661000.0 in the prior quarter.
• The five-year high for Cash from Operations was 18811000.0 in Q2 2025, with the low at 25899000.0 in Q3 2023.
• Historically, Cash from Operations has averaged 3106000.0 across 5 years, with a median of 1370000.0 in 2023.
• Annual changes were most pronounced in 2022 — Cash from Operations surged 286.35% — and 2024, when it sank 1014.31%.
• Angiodynamics' Cash from Operations stood at 7499000.0 in 2022, then fell by 29.78% to 5266000.0 in 2023, then plunged by 53.04% to 2473000.0 in 2024, then surged by 88.48% to 4661000.0 in 2025, then tumbled by 166.72% to 3110000.0 in 2026.
• The last three Cash from Operations figures came in at 3110000.0 (Q1 2026), 4661000.0 (Q4 2025), and 15914000.0 (Q3 2025), per Business Quant data.